Phytotherapy Research

Papers
(The H4-Index of Phytotherapy Research is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Potential effects of curcumin in the treatment of COVID‐19 infection215
A role for quercetin in coronavirus disease 2019 (COVID‐19)180
Quercetin and its derivates as antiviral potentials: A comprehensive review160
Naringenin, a flavanone with antiviral and anti‐inflammatory effects: A promising treatment strategy against COVID‐19155
Natural products and their derivatives against coronavirus: A review of the non‐clinical and pre‐clinical data155
Piperine: A review of its biological effects151
Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID‐19: A review146
Quercetin and metabolic syndrome: A review139
Natural products for COVID‐19 prevention and treatment regarding to previous coronavirus infections and novel studies121
Therapeutic benefits of rutin and its nanoformulations116
Natural products: A lead for drug discovery and development102
Molecular mechanisms of anticancer effect of rutin94
Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects93
Ginger (Zingiber officinale Rosc.) and its bioactive components are potential resources for health beneficial agents85
Beneficial effects of Trichoderma secondary metabolites on crops81
Oral nano‐curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease‐19 patients: An open label nonrandomized clinical trial80
Botanical drugs and supplements affecting the immune response in the time of COVID‐19: Implications for research and clinical practice75
In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS‐CoV‐2 main protease (3CLpro)73
Bee products as a source of promising therapeutic and chemoprophylaxis strategies against COVID‐19 (SARS‐CoV‐2)73
Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in cultured Vero cells73
Natural compounds against doxorubicin‐induced cardiotoxicity: A review on the involvement of Nrf2/ARE signaling pathway71
Efficacy and safety of Xiyanping injection in the treatment of COVID‐19: A multicenter, prospective, open‐label and randomized controlled trial68
Food as medicine: A possible preventive measure against coronavirus disease (COVID‐19)67
The effect of green tea supplementation on obesity: A systematic review and dose–response meta‐analysis of randomized controlled trials64
Effects of essential oils on central nervous system: Focus on mental health64
Biological and pharmacological effects and nutritional impact of phytosterols: A comprehensive review64
Fruits of Terminalia chebula Retz.: A review on traditional uses, bioactive chemical constituents and pharmacological activities63
Ficus plants: State of the art from a phytochemical, pharmacological, and toxicological perspective61
The review of alpha‐linolenic acid: Sources, metabolism, and pharmacology61
Anticancer activity of the plant flavonoid luteolin against preclinical models of various cancers and insights on different signalling mechanisms modulated61
Diabetes and plant‐derived natural products: From ethnopharmacological approaches to their potential for modern drug discovery and development60
Natural products as home‐based prophylactic and symptom management agents in the setting of COVID‐1957
Ganoderma lucidum (Reishi) an edible mushroom; a comprehensive and critical review of its nutritional, cosmeceutical, mycochemical, pharmacological, clinical, and toxicological properties57
Curcumin nanoformulations: Beneficial nanomedicine against cancer56
Glycyrrhizin: An old weapon against a novel coronavirus55
Spices and herbs: Potential antiviral preventives and immunity boosters during COVID‐1954
Wogonin and its analogs for the prevention and treatment of cancer: A systematic review54
Curcumin supplementation in pediatric patients: A systematic review of current clinical evidence53
A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents52
Anti‐inflammatory effect of Rhein on ulcerative colitis via inhibiting PI3K/Akt/mTOR signaling pathway and regulating gut microbiota52
Astaxanthin, COVID‐19 and immune response: Focus on oxidative stress, apoptosis and autophagy52
Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials51
A triple‐blind, placebo‐controlled, randomized clinical trial to evaluate the effect of curcumin‐containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID‐51
A comprehensive review of the therapeutic potential of α‐arbutin49
Curcumin downregulates the PI3K–AKT–mTOR pathway and inhibits growth and progression in head and neck cancer cells48
Quercetin as a protective agent for liver diseases: A comprehensive descriptive review of the molecular mechanism47
Emodin alleviates LPS‐induced myocardial injury through inhibition of NLRP3 inflammasome activation47
The role of medicinal products in the treatment of inflammatory bowel diseases (IBD) through inhibition of TLR4/NF‐kappaB pathway47
Bio‐actives of betel leaf (Piper betle L.): A comprehensive review on extraction, isolation, characterization, and biological activity47
0.042152881622314